Gabor Marth and Mark Yandell are co-directors of the newly launched USTAR Center for Genetic Discovery, which will be housed at the University of Utah School of Medicine. The center will develop and commercialize computational methods for the discovery of relationships between genes and disease.
Marth, who will also serve as a professor of genetics at USTAR, was previously an associate professor of biology at Boston College. He holds a PhD from Washington University in St. Louis.
Yandell has been a faculty member at the University of Utah's Eccles Institute of Human Genetics since 2004. Prior to that, he was a senior scientist with Howard Hughes Medical Institute at the University of California, Berkeley. He holds a PhD from the University of Colorado, Boulder.
Agilent has appointed Biogen Idec CEO George Scangos to its board of directors, effective in September.
Prior to Biogen, Scangos served as president and CEO of Exelixis, a drug discovery and development company. He was previously president of Bayer Biotechnology.